These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 3413082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.
    Garcia DL, Rennke HG, Brenner BM, Anderson S.
    J Clin Invest; 1987 Sep; 80(3):867-74. PubMed ID: 3040810
    [Abstract] [Full Text] [Related]

  • 4. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 5. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J, Koch KM.
    Clin Nephrol; 1995 Nov 15; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension.
    Lafferty HM, Garcia DL, Rennke HG, Troy JL, Anderson S, Brenner BM.
    J Am Soc Nephrol; 1991 Apr 15; 1(10):1180-5. PubMed ID: 1768813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM, Leschke M, Strauer BE, Heidland A.
    Am J Nephrol; 1988 Apr 15; 8(6):449-53. PubMed ID: 3218658
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S, Meyer TW, Rennke HG, Brenner BM.
    J Clin Invest; 1985 Aug 15; 76(2):612-9. PubMed ID: 2993362
    [Abstract] [Full Text] [Related]

  • 13. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP, Raij L.
    Hypertension; 1990 Oct 15; 16(4):452-61. PubMed ID: 2210813
    [Abstract] [Full Text] [Related]

  • 14. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM, Heidland A.
    Dtsch Med Wochenschr; 1989 Jun 30; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract] [Full Text] [Related]

  • 15. A case of erythropoietin induced hypertension in a bilaterally nephrectomized patient.
    Sasaki N, Ando Y, Kusano E, Asano Y.
    ASAIO J; 2003 Jun 30; 49(1):131-5. PubMed ID: 12558321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW, Adamson JW.
    Am J Kidney Dis; 1989 Aug 30; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [Abstract] [Full Text] [Related]

  • 20. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 30; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.